Havrix™ Junior

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Influenza

Phase 3

A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children

CompletedNCT01379937

GlaxoSmithKlineInfluenza

Start: 2011-07-28End: 2012-10-05Updated: 2018-09-07

Phase 4

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

CompletedNCT01196026

GlaxoSmithKlineInfluenza

Start: 2010-09-15End: 2011-05-26Updated: 2018-09-24

Related Papers

Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine: A Randomized Trial in Children of Three to Less Than Eighteen Years of Age.

2016-02-014 citations